Market closedNon-fractional

MiNK Therapeutics/INKT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About MiNK Therapeutics

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Ticker

INKT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

New York, United States

Employees

31

INKT Metrics

BasicAdvanced
$36M
Market cap
-
P/E ratio
-$0.60
EPS
0.05
Beta
-
Dividend rate
$36M
0.05
0.54
0.524
-20.747
-20.747
-111.24%
166.18%
-1.59
-1.59
-2.269
-22.49%
-2.98%

What the Analysts think about INKT

Analyst Ratings

Majority rating from 4 analysts.
Buy

INKT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$3.8M
-29.63%
Profit margin
0.00%
NaN%

INKT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 28.26%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.18
-$0.15
-$0.16
-$0.11
-
Expected
-$0.20
-$0.18
-$0.15
-$0.15
-$0.10
Surprise
-8.86%
-17.81%
4.35%
-28.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for MiNK Therapeutics stock?

MiNK Therapeutics (INKT) has a market cap of $36M as of July 06, 2024.

What is the P/E ratio for MiNK Therapeutics stock?

The price to earnings (P/E) ratio for MiNK Therapeutics (INKT) stock is 0 as of July 06, 2024.

Does MiNK Therapeutics stock pay dividends?

No, MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next MiNK Therapeutics dividend payment date?

MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders.

What is the beta indicator for MiNK Therapeutics?

MiNK Therapeutics (INKT) has a beta rating of 0.05. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell MiNK Therapeutics stock

Buy or sell MiNK Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing